What is the recommended dosage and usage of ulipristal (generic name) for emergency contraception in a female patient of reproductive age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ulipristal Acetate for Emergency Contraception

Administer ulipristal acetate as a single 30 mg oral dose as soon as possible within 120 hours (5 days) of unprotected sexual intercourse. 1

Dosing and Administration

  • The recommended dose is 30 mg taken as a single oral tablet 1
  • Take as soon as possible within 5 days (120 hours) of unprotected intercourse 1, 2
  • Earlier administration is preferable, though efficacy remains consistent throughout the entire 120-hour window 2, 3

Why Ulipristal Acetate is Preferred

Ulipristal acetate maintains superior effectiveness compared to levonorgestrel, particularly when taken 3-5 days after unprotected intercourse. 1, 2

Comparative Effectiveness:

  • Within 72 hours: Ulipristal acetate is at least as effective as levonorgestrel, with some evidence suggesting greater efficacy even in this early window (0.9% vs 2.5% pregnancy rate at <24 hours) 4, 3
  • Between 72-120 hours: Ulipristal acetate is significantly more effective than levonorgestrel, which shows markedly decreased efficacy after 72 hours 1, 2
  • Observed pregnancy rate: 1.3% when taken between 96-120 hours after intercourse 5, 3

Special Populations:

  • Ulipristal acetate may be more effective than levonorgestrel in women who are overweight or obese (BMI >25 kg/m² or weight >75 kg), as levonorgestrel shows reduced effectiveness in this population 2, 5, 6, 7

Mechanism of Action

  • Ulipristal acetate works by inhibiting or delaying ovulation 2, 8
  • It delays the luteinizing hormone (LH) surge or postpones LH peak if surge has already started 8
  • May directly inhibit follicular rupture when administered just before ovulation 8
  • Does not cause abortion or harm an established pregnancy 6

Critical Post-Administration Instructions

After taking ulipristal acetate, any regular contraceptive method can be started immediately, but barrier contraception or abstinence is required for 14 consecutive days or until the next menstrual period, whichever comes first. 2, 5

Contraceptive Restart Protocol:

  • Start or resume hormonal contraception immediately after ulipristal acetate use 2, 5
  • Use barrier method (condoms) or abstain from intercourse for 14 days after ulipristal acetate 2, 5
  • This 14-day backup period is longer than the 7-day period required after levonorgestrel 5

Common Pitfall to Avoid:

The extended 14-day backup contraception requirement after ulipristal acetate is frequently overlooked. This is critical because ulipristal acetate's progesterone receptor modulator activity may theoretically reduce the effectiveness of progestin-containing contraceptives if started immediately without backup 2, 5.

Follow-Up Recommendations

  • Perform a pregnancy test if withdrawal bleeding does not occur within 3 weeks after taking ulipristal acetate 2
  • Menstrual onset is typically delayed by 2-3 days following treatment 8, 3

Tolerability Profile

  • Generally well tolerated with a similar safety profile to levonorgestrel 8, 3
  • Most common adverse effects (>10%): headache, nausea, and abdominal pain 3
  • Side effects are mild and self-limiting 4

Advance Provision

  • An advance supply of ulipristal acetate may be provided to ensure availability and enable prompt use when needed 1, 5
  • Advance provision increases likelihood of timely use after unprotected intercourse 5

Prescription Status

  • Ulipristal acetate requires a prescription in the United States, unlike levonorgestrel which is available over-the-counter 6, 7
  • This prescription requirement may delay access, making advance provision particularly valuable 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Effects of Ulipristal Acetate as an Emergency Contraceptive

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update on emergency contraception.

Advances in therapy, 2011

Guideline

Emergency Contraception Use with Combined Oral Contraceptives and Depot Medroxyprogesterone Acetate

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Emergency contraception: a review.

Minerva ginecologica, 2014

Research

Emergency Contraception.

Mayo Clinic proceedings, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.